context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. | text | 7 | monetaryItemType | text: <entity> 7 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. </context> | us-gaap:ProceedsFromStockOptionsExercised |
The weighted average remaining contractual life of the options outstanding and exercisable as of December 31, 2024 is 1.0 years. The total aggregate intrinsic value of the exercisable stock options as of December 31, 2024 was approximately $ 11 million. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> The weighted average remaining contractual life of the options outstanding and exercisable as of December 31, 2024 is 1.0 years. The total aggregate intrinsic value of the exercisable stock options as of December 31, 2024 was approximately $ 11 million. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue |
As of December 31, 2024, there are 992,478 performance awards outstanding with an intrinsic value of approximately $ 195 million. | text | 992478 | sharesItemType | text: <entity> 992478 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there are 992,478 performance awards outstanding with an intrinsic value of approximately $ 195 million. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
As of December 31, 2024, there are 992,478 performance awards outstanding with an intrinsic value of approximately $ 195 million. | text | 195 | monetaryItemType | text: <entity> 195 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there are 992,478 performance awards outstanding with an intrinsic value of approximately $ 195 million. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
The Company’s RSUs will settle in shares of the Company’s common stock within 30 days of the applicable vesting date. In general, RSUs granted to employees vest either (i) one-third per year beginning on the first anniversary of the grant date or (ii) 100 % at the end of the three-year period following the grant date. Members of the Company’s Board receive RSUs that are fully vested when granted. | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company’s RSUs will settle in shares of the Company’s common stock within 30 days of the applicable vesting date. In general, RSUs granted to employees vest either (i) one-third per year beginning on the first anniversary of the grant date or (ii) 100 % at the end of the three-year period following the grant date. Members of the Company’s Board receive RSUs that are fully vested when granted. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
(1) Pursuant to the IQVIA Holdings Inc. Non-Employee Director Deferral Plan (the “Director Deferral Plan”), non-employee directors may elect to defer receipt of their cash and/or equity retainers. If a director elects to defer his or her retainer, he or she will instead be credited with that value in deferred shares under the Director Deferral Plan. Deferred shares become payable in Company common stock following a termination of the director’s Board service or the director’s death, or upon a change in control of the Company. The Company granted 6,482 deferred RSUs in 2024. | text | 6482 | sharesItemType | text: <entity> 6482 </entity> <entity type> sharesItemType </entity type> <context> (1) Pursuant to the IQVIA Holdings Inc. Non-Employee Director Deferral Plan (the “Director Deferral Plan”), non-employee directors may elect to defer receipt of their cash and/or equity retainers. If a director elects to defer his or her retainer, he or she will instead be credited with that value in deferred shares under the Director Deferral Plan. Deferred shares become payable in Company common stock following a termination of the director’s Board service or the director’s death, or upon a change in control of the Company. The Company granted 6,482 deferred RSUs in 2024. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod |
As of December 31, 2024, there are 1,000,328 RSUs outstanding with an intrinsic value of approximately $ 197 million. | text | 1000328 | sharesItemType | text: <entity> 1000328 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there are 1,000,328 RSUs outstanding with an intrinsic value of approximately $ 197 million. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber |
As of December 31, 2024, there are 1,000,328 RSUs outstanding with an intrinsic value of approximately $ 197 million. | text | 197 | monetaryItemType | text: <entity> 197 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, there are 1,000,328 RSUs outstanding with an intrinsic value of approximately $ 197 million. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 109.83 | perShareItemType | text: <entity> 109.83 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 152.17 | perShareItemType | text: <entity> 152.17 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 147.41 | perShareItemType | text: <entity> 147.41 </entity> <entity type> perShareItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 11 | monetaryItemType | text: <entity> 11 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards |
As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, 2023 and 2022, the weighted average fair value per share of the CSRs outstanding was $ 109.83 , $ 152.17 and $ 147.41 , respectively. The Company paid approximately $ 3 million, $ 11 million and $ 1 million to settle exercised CSRs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards |
The Company’s cash settled RSUs (“Cash RSUs”) require the Company to settle in cash an amount equal to the fair value of the Company’s common stock on the vest date multiplied by the number of vested Cash RSUs. These awards vest either (i) 100 % at the end of the | text | 100 | percentItemType | text: <entity> 100 </entity> <entity type> percentItemType </entity type> <context> The Company’s cash settled RSUs (“Cash RSUs”) require the Company to settle in cash an amount equal to the fair value of the Company’s common stock on the vest date multiplied by the number of vested Cash RSUs. These awards vest either (i) 100 % at the end of the </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage |
-year period following the date of grant, or (ii) one-third per year beginning on the first grant date anniversary. As of December 31, 2024, there are 5,808 Cash RSUs outstanding with an intrinsic value of approximately $ 1 million. | text | 5808 | sharesItemType | text: <entity> 5808 </entity> <entity type> sharesItemType </entity type> <context> -year period following the date of grant, or (ii) one-third per year beginning on the first grant date anniversary. As of December 31, 2024, there are 5,808 Cash RSUs outstanding with an intrinsic value of approximately $ 1 million. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber |
-year period following the date of grant, or (ii) one-third per year beginning on the first grant date anniversary. As of December 31, 2024, there are 5,808 Cash RSUs outstanding with an intrinsic value of approximately $ 1 million. | text | 1 | monetaryItemType | text: <entity> 1 </entity> <entity type> monetaryItemType </entity type> <context> -year period following the date of grant, or (ii) one-third per year beginning on the first grant date anniversary. As of December 31, 2024, there are 5,808 Cash RSUs outstanding with an intrinsic value of approximately $ 1 million. </context> | us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding |
During the year ended December 31, 2022, the Company entered into long term incentive award agreements with certain employees totaling a fixed monetary amount of $ 80 million to issue a variable number of common shares based on the fair market value when the awards vest on the third anniversary of the grant date. The Company accounts for the awards as liability-classified awards with the liability recorded in other current liabilities in the consolidated balance sheets as of December 31, 2024. The Company recorded approximately $ 26 million, $ 22 million and | text | 26 | monetaryItemType | text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, the Company entered into long term incentive award agreements with certain employees totaling a fixed monetary amount of $ 80 million to issue a variable number of common shares based on the fair market value when the awards vest on the third anniversary of the grant date. The Company accounts for the awards as liability-classified awards with the liability recorded in other current liabilities in the consolidated balance sheets as of December 31, 2024. The Company recorded approximately $ 26 million, $ 22 million and </context> | us-gaap:ShareBasedCompensation |
During the year ended December 31, 2022, the Company entered into long term incentive award agreements with certain employees totaling a fixed monetary amount of $ 80 million to issue a variable number of common shares based on the fair market value when the awards vest on the third anniversary of the grant date. The Company accounts for the awards as liability-classified awards with the liability recorded in other current liabilities in the consolidated balance sheets as of December 31, 2024. The Company recorded approximately $ 26 million, $ 22 million and | text | 22 | monetaryItemType | text: <entity> 22 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2022, the Company entered into long term incentive award agreements with certain employees totaling a fixed monetary amount of $ 80 million to issue a variable number of common shares based on the fair market value when the awards vest on the third anniversary of the grant date. The Company accounts for the awards as liability-classified awards with the liability recorded in other current liabilities in the consolidated balance sheets as of December 31, 2024. The Company recorded approximately $ 26 million, $ 22 million and </context> | us-gaap:ShareBasedCompensation |
The following table presents the Company’s operations by reportable segment. The Company is managed through three reportable segments, Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real world insights and services to the Company’s life science clients. Research & Development Solutions, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. | text | three | integerItemType | text: <entity> three </entity> <entity type> integerItemType </entity type> <context> The following table presents the Company’s operations by reportable segment. The Company is managed through three reportable segments, Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions provides mission critical information, technology solutions and real world insights and services to the Company’s life science clients. Research & Development Solutions, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. </context> | us-gaap:NumberOfReportableSegments |
For the years ended December 31, 2024, 2023 and 2022 the weighted average number of outstanding stock-based awards not included in the computation of diluted earnings per share because they are subject to performance conditions that have not been met at the end of the reporting period or the effect of including such stock-based awards in the computation would be anti-dilutive was 1.0 million, 1.0 million, and 0.5 million, million, respectively. | text | 1.0 | sharesItemType | text: <entity> 1.0 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022 the weighted average number of outstanding stock-based awards not included in the computation of diluted earnings per share because they are subject to performance conditions that have not been met at the end of the reporting period or the effect of including such stock-based awards in the computation would be anti-dilutive was 1.0 million, 1.0 million, and 0.5 million, million, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
For the years ended December 31, 2024, 2023 and 2022 the weighted average number of outstanding stock-based awards not included in the computation of diluted earnings per share because they are subject to performance conditions that have not been met at the end of the reporting period or the effect of including such stock-based awards in the computation would be anti-dilutive was 1.0 million, 1.0 million, and 0.5 million, million, respectively. | text | 0.5 | sharesItemType | text: <entity> 0.5 </entity> <entity type> sharesItemType </entity type> <context> For the years ended December 31, 2024, 2023 and 2022 the weighted average number of outstanding stock-based awards not included in the computation of diluted earnings per share because they are subject to performance conditions that have not been met at the end of the reporting period or the effect of including such stock-based awards in the computation would be anti-dilutive was 1.0 million, 1.0 million, and 0.5 million, million, respectively. </context> | us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount |
Intangible assets are acquired assets that lack physical substance but can be distinguished from goodwill because of contractual or other legal rights or because the asset is capable of being sold or exchanged either on its own or in combination with a related contract, asset or liability. The Company had $ 1.5 million of goodwill at both December 31, 2023 and December 31, 2022. Intangible assets with definite useful lives are amortized over their estimated life. No amortization expense related to intangible assets was recorded during the year ended December 31, 2023, as compared to $ 338,000 and $ 405,000 during the years ended December 31, 2022 and 2021, respectively. Goodwill and intangible assets are tested for impairment at least annually or whenever changes in circumstances indicate the carrying amount of the assets may not be recoverable from future undiscounted cash flows. If impaired, the assets are recorded at fair value. In 2023 and 2022, the annual test of goodwill impairment was performed, and in both periods, no impairment was indicated. | text | No | monetaryItemType | text: <entity> No </entity> <entity type> monetaryItemType </entity type> <context> Intangible assets are acquired assets that lack physical substance but can be distinguished from goodwill because of contractual or other legal rights or because the asset is capable of being sold or exchanged either on its own or in combination with a related contract, asset or liability. The Company had $ 1.5 million of goodwill at both December 31, 2023 and December 31, 2022. Intangible assets with definite useful lives are amortized over their estimated life. No amortization expense related to intangible assets was recorded during the year ended December 31, 2023, as compared to $ 338,000 and $ 405,000 during the years ended December 31, 2022 and 2021, respectively. Goodwill and intangible assets are tested for impairment at least annually or whenever changes in circumstances indicate the carrying amount of the assets may not be recoverable from future undiscounted cash flows. If impaired, the assets are recorded at fair value. In 2023 and 2022, the annual test of goodwill impairment was performed, and in both periods, no impairment was indicated. </context> | us-gaap:AmortizationOfIntangibleAssets |
Intangible assets are acquired assets that lack physical substance but can be distinguished from goodwill because of contractual or other legal rights or because the asset is capable of being sold or exchanged either on its own or in combination with a related contract, asset or liability. The Company had $ 1.5 million of goodwill at both December 31, 2023 and December 31, 2022. Intangible assets with definite useful lives are amortized over their estimated life. No amortization expense related to intangible assets was recorded during the year ended December 31, 2023, as compared to $ 338,000 and $ 405,000 during the years ended December 31, 2022 and 2021, respectively. Goodwill and intangible assets are tested for impairment at least annually or whenever changes in circumstances indicate the carrying amount of the assets may not be recoverable from future undiscounted cash flows. If impaired, the assets are recorded at fair value. In 2023 and 2022, the annual test of goodwill impairment was performed, and in both periods, no impairment was indicated. | text | 338000 | monetaryItemType | text: <entity> 338000 </entity> <entity type> monetaryItemType </entity type> <context> Intangible assets are acquired assets that lack physical substance but can be distinguished from goodwill because of contractual or other legal rights or because the asset is capable of being sold or exchanged either on its own or in combination with a related contract, asset or liability. The Company had $ 1.5 million of goodwill at both December 31, 2023 and December 31, 2022. Intangible assets with definite useful lives are amortized over their estimated life. No amortization expense related to intangible assets was recorded during the year ended December 31, 2023, as compared to $ 338,000 and $ 405,000 during the years ended December 31, 2022 and 2021, respectively. Goodwill and intangible assets are tested for impairment at least annually or whenever changes in circumstances indicate the carrying amount of the assets may not be recoverable from future undiscounted cash flows. If impaired, the assets are recorded at fair value. In 2023 and 2022, the annual test of goodwill impairment was performed, and in both periods, no impairment was indicated. </context> | us-gaap:AmortizationOfIntangibleAssets |
Intangible assets are acquired assets that lack physical substance but can be distinguished from goodwill because of contractual or other legal rights or because the asset is capable of being sold or exchanged either on its own or in combination with a related contract, asset or liability. The Company had $ 1.5 million of goodwill at both December 31, 2023 and December 31, 2022. Intangible assets with definite useful lives are amortized over their estimated life. No amortization expense related to intangible assets was recorded during the year ended December 31, 2023, as compared to $ 338,000 and $ 405,000 during the years ended December 31, 2022 and 2021, respectively. Goodwill and intangible assets are tested for impairment at least annually or whenever changes in circumstances indicate the carrying amount of the assets may not be recoverable from future undiscounted cash flows. If impaired, the assets are recorded at fair value. In 2023 and 2022, the annual test of goodwill impairment was performed, and in both periods, no impairment was indicated. | text | 405000 | monetaryItemType | text: <entity> 405000 </entity> <entity type> monetaryItemType </entity type> <context> Intangible assets are acquired assets that lack physical substance but can be distinguished from goodwill because of contractual or other legal rights or because the asset is capable of being sold or exchanged either on its own or in combination with a related contract, asset or liability. The Company had $ 1.5 million of goodwill at both December 31, 2023 and December 31, 2022. Intangible assets with definite useful lives are amortized over their estimated life. No amortization expense related to intangible assets was recorded during the year ended December 31, 2023, as compared to $ 338,000 and $ 405,000 during the years ended December 31, 2022 and 2021, respectively. Goodwill and intangible assets are tested for impairment at least annually or whenever changes in circumstances indicate the carrying amount of the assets may not be recoverable from future undiscounted cash flows. If impaired, the assets are recorded at fair value. In 2023 and 2022, the annual test of goodwill impairment was performed, and in both periods, no impairment was indicated. </context> | us-gaap:AmortizationOfIntangibleAssets |
(1) Excludes accrued interest receivable of $ 9.5 million and $ 6.6 million at December 31, 2023 and December 31, 2022, respectively, related to available-for-sale debt securities and $ 1.4 million and $ 1.5 million at December 31, 2023 and December 31, 2022, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. | text | 9.5 | monetaryItemType | text: <entity> 9.5 </entity> <entity type> monetaryItemType </entity type> <context> (1) Excludes accrued interest receivable of $ 9.5 million and $ 6.6 million at December 31, 2023 and December 31, 2022, respectively, related to available-for-sale debt securities and $ 1.4 million and $ 1.5 million at December 31, 2023 and December 31, 2022, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. </context> | us-gaap:InterestReceivable |
(1) Excludes accrued interest receivable of $ 9.5 million and $ 6.6 million at December 31, 2023 and December 31, 2022, respectively, related to available-for-sale debt securities and $ 1.4 million and $ 1.5 million at December 31, 2023 and December 31, 2022, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. | text | 6.6 | monetaryItemType | text: <entity> 6.6 </entity> <entity type> monetaryItemType </entity type> <context> (1) Excludes accrued interest receivable of $ 9.5 million and $ 6.6 million at December 31, 2023 and December 31, 2022, respectively, related to available-for-sale debt securities and $ 1.4 million and $ 1.5 million at December 31, 2023 and December 31, 2022, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. </context> | us-gaap:InterestReceivable |
(1) Excludes accrued interest receivable of $ 9.5 million and $ 6.6 million at December 31, 2023 and December 31, 2022, respectively, related to available-for-sale debt securities and $ 1.4 million and $ 1.5 million at December 31, 2023 and December 31, 2022, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> (1) Excludes accrued interest receivable of $ 9.5 million and $ 6.6 million at December 31, 2023 and December 31, 2022, respectively, related to available-for-sale debt securities and $ 1.4 million and $ 1.5 million at December 31, 2023 and December 31, 2022, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. </context> | us-gaap:InterestReceivable |
(1) Excludes accrued interest receivable of $ 9.5 million and $ 6.6 million at December 31, 2023 and December 31, 2022, respectively, related to available-for-sale debt securities and $ 1.4 million and $ 1.5 million at December 31, 2023 and December 31, 2022, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. | text | 1.5 | monetaryItemType | text: <entity> 1.5 </entity> <entity type> monetaryItemType </entity type> <context> (1) Excludes accrued interest receivable of $ 9.5 million and $ 6.6 million at December 31, 2023 and December 31, 2022, respectively, related to available-for-sale debt securities and $ 1.4 million and $ 1.5 million at December 31, 2023 and December 31, 2022, respectively, related to held-to-maturity debt securities that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. </context> | us-gaap:InterestReceivable |
In the first quarter of 2023, the Company sold U.S. Treasury securities with an amortized cost of $ 56.4 million and realized a gain of $ 489,000 . | text | 489000 | monetaryItemType | text: <entity> 489000 </entity> <entity type> monetaryItemType </entity type> <context> In the first quarter of 2023, the Company sold U.S. Treasury securities with an amortized cost of $ 56.4 million and realized a gain of $ 489,000 . </context> | us-gaap:DebtSecuritiesRealizedGainLoss |
At December 31, 2023, the Company had 108 available-for-sale debt securities in an unrealized loss position, comprised of 11 U.S. Treasury securities, five U.S. government agency securities, 90 residential mortgage-backed securities and two CRT securities. The unrealized losses on the available-for-sale debt securities were the result of changes in market interest rates compared to the date the securities were acquired rather than the credit quality of the issuers or underlying loans. The Company does not currently intend to sell and based on current conditions it does not believe it is likely that the Company will be required to sell these available-for-sale debt securities before recovery of the amortized cost of such securities in an unrealized loss position and has, therefore recorded the unrealized losses related to this portfolio in AOCI. Held-to-maturity securities consist of government guaranteed securities for which no loss is expected. At December 31, 2023 and December 31, 2022, no allowance for credit losses was established for available-for-sale or held-to-maturity debt securities. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, the Company had 108 available-for-sale debt securities in an unrealized loss position, comprised of 11 U.S. Treasury securities, five U.S. government agency securities, 90 residential mortgage-backed securities and two CRT securities. The unrealized losses on the available-for-sale debt securities were the result of changes in market interest rates compared to the date the securities were acquired rather than the credit quality of the issuers or underlying loans. The Company does not currently intend to sell and based on current conditions it does not believe it is likely that the Company will be required to sell these available-for-sale debt securities before recovery of the amortized cost of such securities in an unrealized loss position and has, therefore recorded the unrealized losses related to this portfolio in AOCI. Held-to-maturity securities consist of government guaranteed securities for which no loss is expected. At December 31, 2023 and December 31, 2022, no allowance for credit losses was established for available-for-sale or held-to-maturity debt securities. </context> | us-gaap:DebtSecuritiesHeldToMaturityExcludingAccruedInterestCreditLossExpenseReversal |
At December 31, 2023, debt securities with carrying values of approximately $ 1.6 million were pledged to secure certain customer deposits. At December 31, 2022, debt securities with carrying values of approximately $ 16.1 million and $ 1.4 million were pledged to secure certain customer repurchase agreements and deposits, respectively. | text | 1.6 | monetaryItemType | text: <entity> 1.6 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, debt securities with carrying values of approximately $ 1.6 million were pledged to secure certain customer deposits. At December 31, 2022, debt securities with carrying values of approximately $ 16.1 million and $ 1.4 million were pledged to secure certain customer repurchase agreements and deposits, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleRestricted |
At December 31, 2023, debt securities with carrying values of approximately $ 1.6 million were pledged to secure certain customer deposits. At December 31, 2022, debt securities with carrying values of approximately $ 16.1 million and $ 1.4 million were pledged to secure certain customer repurchase agreements and deposits, respectively. | text | 16.1 | monetaryItemType | text: <entity> 16.1 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, debt securities with carrying values of approximately $ 1.6 million were pledged to secure certain customer deposits. At December 31, 2022, debt securities with carrying values of approximately $ 16.1 million and $ 1.4 million were pledged to secure certain customer repurchase agreements and deposits, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleRestricted |
At December 31, 2023, debt securities with carrying values of approximately $ 1.6 million were pledged to secure certain customer deposits. At December 31, 2022, debt securities with carrying values of approximately $ 16.1 million and $ 1.4 million were pledged to secure certain customer repurchase agreements and deposits, respectively. | text | 1.4 | monetaryItemType | text: <entity> 1.4 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, debt securities with carrying values of approximately $ 1.6 million were pledged to secure certain customer deposits. At December 31, 2022, debt securities with carrying values of approximately $ 16.1 million and $ 1.4 million were pledged to secure certain customer repurchase agreements and deposits, respectively. </context> | us-gaap:DebtSecuritiesAvailableForSaleRestricted |
(1) Excludes accrued interest receivable of $ 118.1 million and $ 100.4 million at December 31, 2023 and December 31, 2022, respectively, that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. | text | 118.1 | monetaryItemType | text: <entity> 118.1 </entity> <entity type> monetaryItemType </entity type> <context> (1) Excludes accrued interest receivable of $ 118.1 million and $ 100.4 million at December 31, 2023 and December 31, 2022, respectively, that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. </context> | us-gaap:InterestReceivable |
(1) Excludes accrued interest receivable of $ 118.1 million and $ 100.4 million at December 31, 2023 and December 31, 2022, respectively, that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. | text | 100.4 | monetaryItemType | text: <entity> 100.4 </entity> <entity type> monetaryItemType </entity type> <context> (1) Excludes accrued interest receivable of $ 118.1 million and $ 100.4 million at December 31, 2023 and December 31, 2022, respectively, that is recorded in accrued interest receivable and other assets on the consolidated balance sheets. </context> | us-gaap:InterestReceivable |
The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. | text | 47.4 | monetaryItemType | text: <entity> 47.4 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. </context> | us-gaap:ProvisionForLoanAndLeaseLosses |
The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. | text | 61.5 | monetaryItemType | text: <entity> 61.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. </context> | us-gaap:ProvisionForLoanAndLeaseLosses |
The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. | text | 50.9 | monetaryItemType | text: <entity> 50.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease |
The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. | text | 19.9 | monetaryItemType | text: <entity> 19.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestAllowanceForCreditLossPeriodIncreaseDecrease |
The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. | text | 738.2 | monetaryItemType | text: <entity> 738.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. | text | 513.2 | monetaryItemType | text: <entity> 513.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company recorded a $ 47.4 million provision for credit losses on loans for the year ended December 31, 2023, compared to $ 61.5 million for the same period of 2022. The $ 47.4 million provision for credit losses on loans resulted primarily from increases in total loans held for investment, criticized and non-accrual loans and net charge-offs during the year ended December 31, 2023. Net charge-offs of $ 50.9 million were recorded during the year ended December 31, 2023, compared to net charge-offs of $ 19.9 million during the same period of 2022. Criticized loans totaled $ 738.2 million at December 31, 2023 and $ 513.2 million at December 31, 2022. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
A loan is considered collateral-dependent when the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the operation or sale of the collateral. At December 31, 2023, the Company had $ 46.0 million in collateral-dependent commercial loans, collateralized by business assets, and $ 12.4 million in collateral-dependent commercial real estate loans, collateralized by real estate. | text | 46.0 | monetaryItemType | text: <entity> 46.0 </entity> <entity type> monetaryItemType </entity type> <context> A loan is considered collateral-dependent when the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the operation or sale of the collateral. At December 31, 2023, the Company had $ 46.0 million in collateral-dependent commercial loans, collateralized by business assets, and $ 12.4 million in collateral-dependent commercial real estate loans, collateralized by real estate. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
A loan is considered collateral-dependent when the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the operation or sale of the collateral. At December 31, 2023, the Company had $ 46.0 million in collateral-dependent commercial loans, collateralized by business assets, and $ 12.4 million in collateral-dependent commercial real estate loans, collateralized by real estate. | text | 12.4 | monetaryItemType | text: <entity> 12.4 </entity> <entity type> monetaryItemType </entity type> <context> A loan is considered collateral-dependent when the borrower is experiencing financial difficulty and repayment is expected to be provided substantially through the operation or sale of the collateral. At December 31, 2023, the Company had $ 46.0 million in collateral-dependent commercial loans, collateralized by business assets, and $ 12.4 million in collateral-dependent commercial real estate loans, collateralized by real estate. </context> | us-gaap:FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss |
As of December 31, 2023, $ 358,000 of non-accrual loans were earning interest income on a cash basis compared to $ 2.2 million as of December 31, 2022. Additionally, $ 37,000 and $ 801,000 of interest income was recognized on non-accrual loans for the years ended December 31, 2023 and 2022, respectively. Accrued interest of $ 3.0 million and $ 1.6 million was reversed during the years ended December 31, 2023 and December 31, 2022, respectively. | text | 37000 | monetaryItemType | text: <entity> 37000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, $ 358,000 of non-accrual loans were earning interest income on a cash basis compared to $ 2.2 million as of December 31, 2022. Additionally, $ 37,000 and $ 801,000 of interest income was recognized on non-accrual loans for the years ended December 31, 2023 and 2022, respectively. Accrued interest of $ 3.0 million and $ 1.6 million was reversed during the years ended December 31, 2023 and December 31, 2022, respectively. </context> | us-gaap:FinancingReceivableNonaccrualInterestIncome |
As of December 31, 2023, $ 358,000 of non-accrual loans were earning interest income on a cash basis compared to $ 2.2 million as of December 31, 2022. Additionally, $ 37,000 and $ 801,000 of interest income was recognized on non-accrual loans for the years ended December 31, 2023 and 2022, respectively. Accrued interest of $ 3.0 million and $ 1.6 million was reversed during the years ended December 31, 2023 and December 31, 2022, respectively. | text | 801000 | monetaryItemType | text: <entity> 801000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2023, $ 358,000 of non-accrual loans were earning interest income on a cash basis compared to $ 2.2 million as of December 31, 2022. Additionally, $ 37,000 and $ 801,000 of interest income was recognized on non-accrual loans for the years ended December 31, 2023 and 2022, respectively. Accrued interest of $ 3.0 million and $ 1.6 million was reversed during the years ended December 31, 2023 and December 31, 2022, respectively. </context> | us-gaap:FinancingReceivableNonaccrualInterestIncome |
During the year ended December 31, 2023, commercial loans totaling $ 6.3 million experienced a default subsequent to being granted a term extension modification in the prior twelve months. Default is defined as movement to nonperforming status, foreclosure or charge-off, whichever occurs first. | text | 6.3 | monetaryItemType | text: <entity> 6.3 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, commercial loans totaling $ 6.3 million experienced a default subsequent to being granted a term extension modification in the prior twelve months. Default is defined as movement to nonperforming status, foreclosure or charge-off, whichever occurs first. </context> | us-gaap:FinancingReceivableModificationsSubsequentDefaultRecordedInvestment1 |
Depreciation and amortization expense for the above premises and equipment was approximately $ 10.4 million, $ 9.5 million and $ 8.1 million in 2023, 2022 and 2021, respectively. | text | 10.4 | monetaryItemType | text: <entity> 10.4 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation and amortization expense for the above premises and equipment was approximately $ 10.4 million, $ 9.5 million and $ 8.1 million in 2023, 2022 and 2021, respectively. </context> | us-gaap:Depreciation |
Depreciation and amortization expense for the above premises and equipment was approximately $ 10.4 million, $ 9.5 million and $ 8.1 million in 2023, 2022 and 2021, respectively. | text | 9.5 | monetaryItemType | text: <entity> 9.5 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation and amortization expense for the above premises and equipment was approximately $ 10.4 million, $ 9.5 million and $ 8.1 million in 2023, 2022 and 2021, respectively. </context> | us-gaap:Depreciation |
Depreciation and amortization expense for the above premises and equipment was approximately $ 10.4 million, $ 9.5 million and $ 8.1 million in 2023, 2022 and 2021, respectively. | text | 8.1 | monetaryItemType | text: <entity> 8.1 </entity> <entity type> monetaryItemType </entity type> <context> Depreciation and amortization expense for the above premises and equipment was approximately $ 10.4 million, $ 9.5 million and $ 8.1 million in 2023, 2022 and 2021, respectively. </context> | us-gaap:Depreciation |
At December 31, 2023 and 2022, interest bearing time deposits greater than $250,000 were approximately $ 376.4 million and $ 258.4 million, respectively. | text | 376.4 | monetaryItemType | text: <entity> 376.4 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023 and 2022, interest bearing time deposits greater than $250,000 were approximately $ 376.4 million and $ 258.4 million, respectively. </context> | us-gaap:TimeDepositsAtOrAboveFDICInsuranceLimit |
At December 31, 2023 and 2022, interest bearing time deposits greater than $250,000 were approximately $ 376.4 million and $ 258.4 million, respectively. | text | 258.4 | monetaryItemType | text: <entity> 258.4 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023 and 2022, interest bearing time deposits greater than $250,000 were approximately $ 376.4 million and $ 258.4 million, respectively. </context> | us-gaap:TimeDepositsAtOrAboveFDICInsuranceLimit |
Unsecured revolving, non-amortizing line of credit with maturity date of February 8, 2025. Proceeds may be used for general corporate purposes, including funding regulatory capital infusions into the Bank. The loan agreement contains customary financial covenants and restrictions. No borrowings were made against this line of credit during the twelve months ended December 31, 2023 or 2022. The line of credit was reduced to $ 75.0 million in the first quarter of 2024. | text | 75.0 | monetaryItemType | text: <entity> 75.0 </entity> <entity type> monetaryItemType </entity type> <context> Unsecured revolving, non-amortizing line of credit with maturity date of February 8, 2025. Proceeds may be used for general corporate purposes, including funding regulatory capital infusions into the Bank. The loan agreement contains customary financial covenants and restrictions. No borrowings were made against this line of credit during the twelve months ended December 31, 2023 or 2022. The line of credit was reduced to $ 75.0 million in the first quarter of 2024. </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
In the second quarter of 2023, the Company partially paid down $ 75.0 million of the senior unsecured credit-linked notes in accordance with the term of the notes. | text | 75.0 | monetaryItemType | text: <entity> 75.0 </entity> <entity type> monetaryItemType </entity type> <context> In the second quarter of 2023, the Company partially paid down $ 75.0 million of the senior unsecured credit-linked notes in accordance with the term of the notes. </context> | us-gaap:RepaymentsOfLongTermDebt |
Additionally, the Basel III Capital Rules require that the Company maintains a 2.5 % capital conservation buffer with respect to each of CET1, Tier 1 and total capital to risk-weighted assets, which provides for capital levels that exceed the minimum risk-based capital adequacy requirements. A financial institution with a conservation buffer of less than the required amount is subject to limitations on capital distributions, including dividend payments and stock repurchases, and certain discretionary bonus payments to executive officers. No dividends were declared or paid on the Company’s common stock during 2023 or 2022. In January 2023, the Company completed the full $ 150.0 million of share repurchases authorized by the Company’s board of directors on April 19, 2022. On January 18, 2023, the Company’s board of directors authorized a new share repurchase program under which the Company could repurchase up to $ 150.0 million in shares of its outstanding common stock. During the year ended December 31, 2023, the Company repurchased 1,821,532 shares of its common stock for an aggregate price, including excise tax expense, of $ 105.0 million, at a weighted average price of $ 57.17 per share. On January 17, 2024, the Company’s board of directors authorized a new share repurchase program under which the Company may repurchase up to $ 150.0 million in shares of its outstanding common stock, which is set to expire on January 31, 2025. Remaining repurchase authorization under the January 18, 2023 share repurchase program was terminated upon authorization of this new program. | text | 150.0 | monetaryItemType | text: <entity> 150.0 </entity> <entity type> monetaryItemType </entity type> <context> Additionally, the Basel III Capital Rules require that the Company maintains a 2.5 % capital conservation buffer with respect to each of CET1, Tier 1 and total capital to risk-weighted assets, which provides for capital levels that exceed the minimum risk-based capital adequacy requirements. A financial institution with a conservation buffer of less than the required amount is subject to limitations on capital distributions, including dividend payments and stock repurchases, and certain discretionary bonus payments to executive officers. No dividends were declared or paid on the Company’s common stock during 2023 or 2022. In January 2023, the Company completed the full $ 150.0 million of share repurchases authorized by the Company’s board of directors on April 19, 2022. On January 18, 2023, the Company’s board of directors authorized a new share repurchase program under which the Company could repurchase up to $ 150.0 million in shares of its outstanding common stock. During the year ended December 31, 2023, the Company repurchased 1,821,532 shares of its common stock for an aggregate price, including excise tax expense, of $ 105.0 million, at a weighted average price of $ 57.17 per share. On January 17, 2024, the Company’s board of directors authorized a new share repurchase program under which the Company may repurchase up to $ 150.0 million in shares of its outstanding common stock, which is set to expire on January 31, 2025. Remaining repurchase authorization under the January 18, 2023 share repurchase program was terminated upon authorization of this new program. </context> | us-gaap:StockRepurchaseProgramAuthorizedAmount1 |
Additionally, the Basel III Capital Rules require that the Company maintains a 2.5 % capital conservation buffer with respect to each of CET1, Tier 1 and total capital to risk-weighted assets, which provides for capital levels that exceed the minimum risk-based capital adequacy requirements. A financial institution with a conservation buffer of less than the required amount is subject to limitations on capital distributions, including dividend payments and stock repurchases, and certain discretionary bonus payments to executive officers. No dividends were declared or paid on the Company’s common stock during 2023 or 2022. In January 2023, the Company completed the full $ 150.0 million of share repurchases authorized by the Company’s board of directors on April 19, 2022. On January 18, 2023, the Company’s board of directors authorized a new share repurchase program under which the Company could repurchase up to $ 150.0 million in shares of its outstanding common stock. During the year ended December 31, 2023, the Company repurchased 1,821,532 shares of its common stock for an aggregate price, including excise tax expense, of $ 105.0 million, at a weighted average price of $ 57.17 per share. On January 17, 2024, the Company’s board of directors authorized a new share repurchase program under which the Company may repurchase up to $ 150.0 million in shares of its outstanding common stock, which is set to expire on January 31, 2025. Remaining repurchase authorization under the January 18, 2023 share repurchase program was terminated upon authorization of this new program. | text | 1821532 | sharesItemType | text: <entity> 1821532 </entity> <entity type> sharesItemType </entity type> <context> Additionally, the Basel III Capital Rules require that the Company maintains a 2.5 % capital conservation buffer with respect to each of CET1, Tier 1 and total capital to risk-weighted assets, which provides for capital levels that exceed the minimum risk-based capital adequacy requirements. A financial institution with a conservation buffer of less than the required amount is subject to limitations on capital distributions, including dividend payments and stock repurchases, and certain discretionary bonus payments to executive officers. No dividends were declared or paid on the Company’s common stock during 2023 or 2022. In January 2023, the Company completed the full $ 150.0 million of share repurchases authorized by the Company’s board of directors on April 19, 2022. On January 18, 2023, the Company’s board of directors authorized a new share repurchase program under which the Company could repurchase up to $ 150.0 million in shares of its outstanding common stock. During the year ended December 31, 2023, the Company repurchased 1,821,532 shares of its common stock for an aggregate price, including excise tax expense, of $ 105.0 million, at a weighted average price of $ 57.17 per share. On January 17, 2024, the Company’s board of directors authorized a new share repurchase program under which the Company may repurchase up to $ 150.0 million in shares of its outstanding common stock, which is set to expire on January 31, 2025. Remaining repurchase authorization under the January 18, 2023 share repurchase program was terminated upon authorization of this new program. </context> | us-gaap:StockRepurchasedDuringPeriodShares |
Additionally, the Basel III Capital Rules require that the Company maintains a 2.5 % capital conservation buffer with respect to each of CET1, Tier 1 and total capital to risk-weighted assets, which provides for capital levels that exceed the minimum risk-based capital adequacy requirements. A financial institution with a conservation buffer of less than the required amount is subject to limitations on capital distributions, including dividend payments and stock repurchases, and certain discretionary bonus payments to executive officers. No dividends were declared or paid on the Company’s common stock during 2023 or 2022. In January 2023, the Company completed the full $ 150.0 million of share repurchases authorized by the Company’s board of directors on April 19, 2022. On January 18, 2023, the Company’s board of directors authorized a new share repurchase program under which the Company could repurchase up to $ 150.0 million in shares of its outstanding common stock. During the year ended December 31, 2023, the Company repurchased 1,821,532 shares of its common stock for an aggregate price, including excise tax expense, of $ 105.0 million, at a weighted average price of $ 57.17 per share. On January 17, 2024, the Company’s board of directors authorized a new share repurchase program under which the Company may repurchase up to $ 150.0 million in shares of its outstanding common stock, which is set to expire on January 31, 2025. Remaining repurchase authorization under the January 18, 2023 share repurchase program was terminated upon authorization of this new program. | text | 105.0 | monetaryItemType | text: <entity> 105.0 </entity> <entity type> monetaryItemType </entity type> <context> Additionally, the Basel III Capital Rules require that the Company maintains a 2.5 % capital conservation buffer with respect to each of CET1, Tier 1 and total capital to risk-weighted assets, which provides for capital levels that exceed the minimum risk-based capital adequacy requirements. A financial institution with a conservation buffer of less than the required amount is subject to limitations on capital distributions, including dividend payments and stock repurchases, and certain discretionary bonus payments to executive officers. No dividends were declared or paid on the Company’s common stock during 2023 or 2022. In January 2023, the Company completed the full $ 150.0 million of share repurchases authorized by the Company’s board of directors on April 19, 2022. On January 18, 2023, the Company’s board of directors authorized a new share repurchase program under which the Company could repurchase up to $ 150.0 million in shares of its outstanding common stock. During the year ended December 31, 2023, the Company repurchased 1,821,532 shares of its common stock for an aggregate price, including excise tax expense, of $ 105.0 million, at a weighted average price of $ 57.17 per share. On January 17, 2024, the Company’s board of directors authorized a new share repurchase program under which the Company may repurchase up to $ 150.0 million in shares of its outstanding common stock, which is set to expire on January 31, 2025. Remaining repurchase authorization under the January 18, 2023 share repurchase program was terminated upon authorization of this new program. </context> | us-gaap:StockRepurchasedDuringPeriodValue |
Because the Bank had less than $ 15.0 billion in total consolidated assets as of December 31, 2009, it is allowed to continue to classify the trust preferred securities, all of which were issued prior to May 19, 2010, as Tier 1 capital. | text | 15.0 | monetaryItemType | text: <entity> 15.0 </entity> <entity type> monetaryItemType </entity type> <context> Because the Bank had less than $ 15.0 billion in total consolidated assets as of December 31, 2009, it is allowed to continue to classify the trust preferred securities, all of which were issued prior to May 19, 2010, as Tier 1 capital. </context> | us-gaap:Assets |
The Company has a qualified retirement plan with a salary deferral feature designed to qualify under Section 401 of the Internal Revenue Code (“the 401(k) Plan”). The 401(k) Plan permits employees to defer a portion of their compensation. Matching contributions may be made in amounts and at times determined by the Company. These contributions were approximately $ 15.2 million, $ 13.3 million and $ 10.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. Employees are eligible to participate in the 401(k) Plan when they meet certain requirements concerning minimum age and period of credited service. All contributions to the 401(k) Plan are invested in accordance with participant elections among certain investment options. | text | 15.2 | monetaryItemType | text: <entity> 15.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a qualified retirement plan with a salary deferral feature designed to qualify under Section 401 of the Internal Revenue Code (“the 401(k) Plan”). The 401(k) Plan permits employees to defer a portion of their compensation. Matching contributions may be made in amounts and at times determined by the Company. These contributions were approximately $ 15.2 million, $ 13.3 million and $ 10.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. Employees are eligible to participate in the 401(k) Plan when they meet certain requirements concerning minimum age and period of credited service. All contributions to the 401(k) Plan are invested in accordance with participant elections among certain investment options. </context> | us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer |
The Company has a qualified retirement plan with a salary deferral feature designed to qualify under Section 401 of the Internal Revenue Code (“the 401(k) Plan”). The 401(k) Plan permits employees to defer a portion of their compensation. Matching contributions may be made in amounts and at times determined by the Company. These contributions were approximately $ 15.2 million, $ 13.3 million and $ 10.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. Employees are eligible to participate in the 401(k) Plan when they meet certain requirements concerning minimum age and period of credited service. All contributions to the 401(k) Plan are invested in accordance with participant elections among certain investment options. | text | 13.3 | monetaryItemType | text: <entity> 13.3 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a qualified retirement plan with a salary deferral feature designed to qualify under Section 401 of the Internal Revenue Code (“the 401(k) Plan”). The 401(k) Plan permits employees to defer a portion of their compensation. Matching contributions may be made in amounts and at times determined by the Company. These contributions were approximately $ 15.2 million, $ 13.3 million and $ 10.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. Employees are eligible to participate in the 401(k) Plan when they meet certain requirements concerning minimum age and period of credited service. All contributions to the 401(k) Plan are invested in accordance with participant elections among certain investment options. </context> | us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer |
The Company has a qualified retirement plan with a salary deferral feature designed to qualify under Section 401 of the Internal Revenue Code (“the 401(k) Plan”). The 401(k) Plan permits employees to defer a portion of their compensation. Matching contributions may be made in amounts and at times determined by the Company. These contributions were approximately $ 15.2 million, $ 13.3 million and $ 10.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. Employees are eligible to participate in the 401(k) Plan when they meet certain requirements concerning minimum age and period of credited service. All contributions to the 401(k) Plan are invested in accordance with participant elections among certain investment options. | text | 10.2 | monetaryItemType | text: <entity> 10.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company has a qualified retirement plan with a salary deferral feature designed to qualify under Section 401 of the Internal Revenue Code (“the 401(k) Plan”). The 401(k) Plan permits employees to defer a portion of their compensation. Matching contributions may be made in amounts and at times determined by the Company. These contributions were approximately $ 15.2 million, $ 13.3 million and $ 10.2 million for the years ended December 31, 2023, 2022 and 2021, respectively. Employees are eligible to participate in the 401(k) Plan when they meet certain requirements concerning minimum age and period of credited service. All contributions to the 401(k) Plan are invested in accordance with participant elections among certain investment options. </context> | us-gaap:DeferredCompensationArrangementWithIndividualContributionsByEmployer |
The Company also offers a non-qualified deferred compensation plan for executives and key members of management in order to assist in attracting and retaining these individuals. Participants in the plan may elect to defer up to 75 % of their annual salary and/or short-term incentive payout into deferral accounts that mirror the gains or losses of investments selected by the participants. The plan allows the Company to make discretionary contributions on behalf of a participant as well as matching contributions. The Company did not make any matching contributions in 2023 or 2022, compared to $ 274,000 in 2021. All participant contributions to the plan and any related earnings are immediately vested and may be withdrawn upon the participant's separation from service, death or disability or upon a date specified by the participant. Salary deferrals are recorded as salaries and employee benefits expense on the consolidated statements of income with an offsetting payable to participants in other liabilities on the consolidated balance sheets. | text | 75 | percentItemType | text: <entity> 75 </entity> <entity type> percentItemType </entity type> <context> The Company also offers a non-qualified deferred compensation plan for executives and key members of management in order to assist in attracting and retaining these individuals. Participants in the plan may elect to defer up to 75 % of their annual salary and/or short-term incentive payout into deferral accounts that mirror the gains or losses of investments selected by the participants. The plan allows the Company to make discretionary contributions on behalf of a participant as well as matching contributions. The Company did not make any matching contributions in 2023 or 2022, compared to $ 274,000 in 2021. All participant contributions to the plan and any related earnings are immediately vested and may be withdrawn upon the participant's separation from service, death or disability or upon a date specified by the participant. Salary deferrals are recorded as salaries and employee benefits expense on the consolidated statements of income with an offsetting payable to participants in other liabilities on the consolidated balance sheets. </context> | us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent |
The Company also offers a non-qualified deferred compensation plan for executives and key members of management in order to assist in attracting and retaining these individuals. Participants in the plan may elect to defer up to 75 % of their annual salary and/or short-term incentive payout into deferral accounts that mirror the gains or losses of investments selected by the participants. The plan allows the Company to make discretionary contributions on behalf of a participant as well as matching contributions. The Company did not make any matching contributions in 2023 or 2022, compared to $ 274,000 in 2021. All participant contributions to the plan and any related earnings are immediately vested and may be withdrawn upon the participant's separation from service, death or disability or upon a date specified by the participant. Salary deferrals are recorded as salaries and employee benefits expense on the consolidated statements of income with an offsetting payable to participants in other liabilities on the consolidated balance sheets. | text | 274000 | monetaryItemType | text: <entity> 274000 </entity> <entity type> monetaryItemType </entity type> <context> The Company also offers a non-qualified deferred compensation plan for executives and key members of management in order to assist in attracting and retaining these individuals. Participants in the plan may elect to defer up to 75 % of their annual salary and/or short-term incentive payout into deferral accounts that mirror the gains or losses of investments selected by the participants. The plan allows the Company to make discretionary contributions on behalf of a participant as well as matching contributions. The Company did not make any matching contributions in 2023 or 2022, compared to $ 274,000 in 2021. All participant contributions to the plan and any related earnings are immediately vested and may be withdrawn upon the participant's separation from service, death or disability or upon a date specified by the participant. Salary deferrals are recorded as salaries and employee benefits expense on the consolidated statements of income with an offsetting payable to participants in other liabilities on the consolidated balance sheets. </context> | us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount |
The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardMaximumEmployeeSubscriptionRate |
The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. | text | 400000 | sharesItemType | text: <entity> 400000 </entity> <entity type> sharesItemType </entity type> <context> The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. | text | 210558 | sharesItemType | text: <entity> 210558 </entity> <entity type> sharesItemType </entity type> <context> The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward |
The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. | text | 184263 | sharesItemType | text: <entity> 184263 </entity> <entity type> sharesItemType </entity type> <context> The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward |
The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. | text | 164033 | sharesItemType | text: <entity> 164033 </entity> <entity type> sharesItemType </entity type> <context> The Company has an Employee Stock Purchase Plan (“ESPP”). Employees are eligible for the ESPP when they meet certain requirements concerning period of credited service and minimum hours worked. Eligible employees may contribute between 1 % and 10 % of eligible compensation up to the Section 423 of the Internal Revenue Code limit of $25,000. In 2006, stockholders approved the ESPP, which allocated 400,000 shares for purchase. As of December 31, 2023, 2022 and 2021, 210,558 , 184,263 and 164,033 shares, respectively, had been purchased on behalf of employees under the ESPP. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward |
The Company has stock-based compensation plans under which equity-based compensation grants are made by the board of directors, or its designated committee. Grants are subject to vesting requirements and may be settled in shares of common stock or paid in cash. Under the plans, the Company may grant, among other things, non-qualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights (“SARs”), performance awards or any combination thereof to employees and non-employee directors. A total of 1,400,000 shares are authorized for grant under the current plan. Total shares remaining available for grant under the current plan at December 31, 2023 were 861,366 . | text | 1400000 | sharesItemType | text: <entity> 1400000 </entity> <entity type> sharesItemType </entity type> <context> The Company has stock-based compensation plans under which equity-based compensation grants are made by the board of directors, or its designated committee. Grants are subject to vesting requirements and may be settled in shares of common stock or paid in cash. Under the plans, the Company may grant, among other things, non-qualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights (“SARs”), performance awards or any combination thereof to employees and non-employee directors. A total of 1,400,000 shares are authorized for grant under the current plan. Total shares remaining available for grant under the current plan at December 31, 2023 were 861,366 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized |
The Company has stock-based compensation plans under which equity-based compensation grants are made by the board of directors, or its designated committee. Grants are subject to vesting requirements and may be settled in shares of common stock or paid in cash. Under the plans, the Company may grant, among other things, non-qualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights (“SARs”), performance awards or any combination thereof to employees and non-employee directors. A total of 1,400,000 shares are authorized for grant under the current plan. Total shares remaining available for grant under the current plan at December 31, 2023 were 861,366 . | text | 861366 | sharesItemType | text: <entity> 861366 </entity> <entity type> sharesItemType </entity type> <context> The Company has stock-based compensation plans under which equity-based compensation grants are made by the board of directors, or its designated committee. Grants are subject to vesting requirements and may be settled in shares of common stock or paid in cash. Under the plans, the Company may grant, among other things, non-qualified stock options, incentive stock options, restricted stock, restricted stock units (“RSUs”), stock appreciation rights (“SARs”), performance awards or any combination thereof to employees and non-employee directors. A total of 1,400,000 shares are authorized for grant under the current plan. Total shares remaining available for grant under the current plan at December 31, 2023 were 861,366 . </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The Company may make grants of restricted common stock to various non-employee directors as to which restrictions lapse ratably over a period of three years . No grants of restricted stock were made during 2023, 2022 or 2021 and no compensation expense was recorded during 2023 or 2022, compared to compensation expense of $ 1,000 for the year ended December 31, 2021. As of December 31, 2023, there were no remaining restrictions on any grants of restricted common stock. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> The Company may make grants of restricted common stock to various non-employee directors as to which restrictions lapse ratably over a period of three years . No grants of restricted stock were made during 2023, 2022 or 2021 and no compensation expense was recorded during 2023 or 2022, compared to compensation expense of $ 1,000 for the year ended December 31, 2021. As of December 31, 2023, there were no remaining restrictions on any grants of restricted common stock. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
The Company may make grants of restricted common stock to various non-employee directors as to which restrictions lapse ratably over a period of three years . No grants of restricted stock were made during 2023, 2022 or 2021 and no compensation expense was recorded during 2023 or 2022, compared to compensation expense of $ 1,000 for the year ended December 31, 2021. As of December 31, 2023, there were no remaining restrictions on any grants of restricted common stock. | text | 1000 | monetaryItemType | text: <entity> 1000 </entity> <entity type> monetaryItemType </entity type> <context> The Company may make grants of restricted common stock to various non-employee directors as to which restrictions lapse ratably over a period of three years . No grants of restricted stock were made during 2023, 2022 or 2021 and no compensation expense was recorded during 2023 or 2022, compared to compensation expense of $ 1,000 for the year ended December 31, 2021. As of December 31, 2023, there were no remaining restrictions on any grants of restricted common stock. </context> | us-gaap:AllocatedShareBasedCompensationExpense |
Total compensation cost for grants of stock-settled units was $ 24.2 million, $ 21.2 million and $ 30.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 24.2 | monetaryItemType | text: <entity> 24.2 </entity> <entity type> monetaryItemType </entity type> <context> Total compensation cost for grants of stock-settled units was $ 24.2 million, $ 21.2 million and $ 30.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax |
Total compensation cost for grants of stock-settled units was $ 24.2 million, $ 21.2 million and $ 30.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 21.2 | monetaryItemType | text: <entity> 21.2 </entity> <entity type> monetaryItemType </entity type> <context> Total compensation cost for grants of stock-settled units was $ 24.2 million, $ 21.2 million and $ 30.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax |
Total compensation cost for grants of stock-settled units was $ 24.2 million, $ 21.2 million and $ 30.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. | text | 30.1 | monetaryItemType | text: <entity> 30.1 </entity> <entity type> monetaryItemType </entity type> <context> Total compensation cost for grants of stock-settled units was $ 24.2 million, $ 21.2 million and $ 30.1 million for the years ended December 31, 2023, 2022 and 2021, respectively. </context> | us-gaap:AllocatedShareBasedCompensationExpenseNetOfTax |
At December 31, 2023, 2022 and 2021, the Company had unrecognized tax benefits of $ 1.0 million, $ 889,000 and $ 722,000 , respectively. | text | 1.0 | monetaryItemType | text: <entity> 1.0 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, 2022 and 2021, the Company had unrecognized tax benefits of $ 1.0 million, $ 889,000 and $ 722,000 , respectively. </context> | us-gaap:UnrecognizedTaxBenefits |
At December 31, 2023, 2022 and 2021, the Company had unrecognized tax benefits of $ 1.0 million, $ 889,000 and $ 722,000 , respectively. | text | 889000 | monetaryItemType | text: <entity> 889000 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, 2022 and 2021, the Company had unrecognized tax benefits of $ 1.0 million, $ 889,000 and $ 722,000 , respectively. </context> | us-gaap:UnrecognizedTaxBenefits |
At December 31, 2023, 2022 and 2021, the Company had unrecognized tax benefits of $ 1.0 million, $ 889,000 and $ 722,000 , respectively. | text | 722000 | monetaryItemType | text: <entity> 722000 </entity> <entity type> monetaryItemType </entity type> <context> At December 31, 2023, 2022 and 2021, the Company had unrecognized tax benefits of $ 1.0 million, $ 889,000 and $ 722,000 , respectively. </context> | us-gaap:UnrecognizedTaxBenefits |
Certain collateral-dependent loans held for investment are reported at fair value when, based upon an individual evaluation, the specific allocation of the allowance for credit losses that is deducted from the loan's amortized cost is based upon the fair value of the loan's underlying collateral. The $ 38.3 million fair value of loans held for investment at December 31, 2023 reported above includes impaired loans with a carrying value of $ 58.3 million that were reduced by specific allowance allocations totaling $ 20.0 million based on collateral valuations utilizing Level 3 inputs. There were no collateral-dependent loans held for investment reported at fair value at December 31, 2022. | text | 38.3 | monetaryItemType | text: <entity> 38.3 </entity> <entity type> monetaryItemType </entity type> <context> Certain collateral-dependent loans held for investment are reported at fair value when, based upon an individual evaluation, the specific allocation of the allowance for credit losses that is deducted from the loan's amortized cost is based upon the fair value of the loan's underlying collateral. The $ 38.3 million fair value of loans held for investment at December 31, 2023 reported above includes impaired loans with a carrying value of $ 58.3 million that were reduced by specific allowance allocations totaling $ 20.0 million based on collateral valuations utilizing Level 3 inputs. There were no collateral-dependent loans held for investment reported at fair value at December 31, 2022. </context> | us-gaap:LoansReceivableFairValueDisclosure |
Certain collateral-dependent loans held for investment are reported at fair value when, based upon an individual evaluation, the specific allocation of the allowance for credit losses that is deducted from the loan's amortized cost is based upon the fair value of the loan's underlying collateral. The $ 38.3 million fair value of loans held for investment at December 31, 2023 reported above includes impaired loans with a carrying value of $ 58.3 million that were reduced by specific allowance allocations totaling $ 20.0 million based on collateral valuations utilizing Level 3 inputs. There were no collateral-dependent loans held for investment reported at fair value at December 31, 2022. | text | no | monetaryItemType | text: <entity> no </entity> <entity type> monetaryItemType </entity type> <context> Certain collateral-dependent loans held for investment are reported at fair value when, based upon an individual evaluation, the specific allocation of the allowance for credit losses that is deducted from the loan's amortized cost is based upon the fair value of the loan's underlying collateral. The $ 38.3 million fair value of loans held for investment at December 31, 2023 reported above includes impaired loans with a carrying value of $ 58.3 million that were reduced by specific allowance allocations totaling $ 20.0 million based on collateral valuations utilizing Level 3 inputs. There were no collateral-dependent loans held for investment reported at fair value at December 31, 2022. </context> | us-gaap:LoansReceivableFairValueDisclosure |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 14 | integerItemType | text: <entity> 14 </entity> <entity type> integerItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:DerivativeNumberOfInstrumentsHeld |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 230.7 | monetaryItemType | text: <entity> 230.7 </entity> <entity type> monetaryItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:DerivativeNotionalAmount |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 19 | integerItemType | text: <entity> 19 </entity> <entity type> integerItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:DerivativeNumberOfInstrumentsHeld |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 291.2 | monetaryItemType | text: <entity> 291.2 </entity> <entity type> monetaryItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:DerivativeNotionalAmount |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 4.5 | monetaryItemType | text: <entity> 4.5 </entity> <entity type> monetaryItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:GuaranteeObligationsMaximumExposure |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 8.9 | monetaryItemType | text: <entity> 8.9 </entity> <entity type> monetaryItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:GuaranteeObligationsMaximumExposure |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 15 | integerItemType | text: <entity> 15 </entity> <entity type> integerItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:DerivativeNumberOfInstrumentsHeld |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 204.8 | monetaryItemType | text: <entity> 204.8 </entity> <entity type> monetaryItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:DerivativeNotionalAmount |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 18 | integerItemType | text: <entity> 18 </entity> <entity type> integerItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:DerivativeNumberOfInstrumentsHeld |
The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. | text | 222.0 | monetaryItemType | text: <entity> 222.0 </entity> <entity type> monetaryItemType </entity type> <context> The Company also enters into credit risk participation agreements with financial institution counterparties for interest rate swaps related to loans in which the Company is either a participant or a lead bank. The risk participation agreements entered into by the Company as a participant bank provide credit protection to the financial institution counterparty should the borrower fail to perform on its interest rate derivative contract with that financial institution. The Company is party to 14 risk participation agreements where it acts as a participant bank with a notional amount of $ 230.7 million at December 31, 2023, compared to 19 risk participation agreements with a notional amount of $ 291.2 million at December 31, 2022. The maximum estimated exposure to these agreements, assuming 100% default by all obligors, was approximately $ 4.5 million at December 31, 2023 and $ 8.9 million at December 31, 2022. The fair value of these exposures was insignificant to the consolidated financial statements at both December 31, 2023 and December 31, 2022. Risk participation agreements entered into by the Company as the lead bank provide credit protection should the borrower fail to perform on its interest rate derivative contract. The Company is party to 15 risk participation agreements where the Company acts as the lead bank having a notional amount of $ 204.8 million at December 31, 2023, compared to 18 agreements having a notional amount of $ 222.0 million at December 31, 2022. </context> | us-gaap:DerivativeNotionalAmount |
During the year ended December 31, 2023, the Company recorded $ 34.8 million in unrealized losses to adjust its cash flow hedges to fair value, which was recorded net of tax to AOCI, and reclassified $ 60.9 million from AOCI as a decrease to interest income on loans. Based on current market conditions, the Company estimates that during the next 12 months, an additional $ 53.1 million related to active and terminated hedges will be reclassified from AOCI as a decrease to interest income. As of December 31, 2023, the maximum length of time over which forecasted transactions are hedged is 2.17 . | text | 34.8 | monetaryItemType | text: <entity> 34.8 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company recorded $ 34.8 million in unrealized losses to adjust its cash flow hedges to fair value, which was recorded net of tax to AOCI, and reclassified $ 60.9 million from AOCI as a decrease to interest income on loans. Based on current market conditions, the Company estimates that during the next 12 months, an additional $ 53.1 million related to active and terminated hedges will be reclassified from AOCI as a decrease to interest income. As of December 31, 2023, the maximum length of time over which forecasted transactions are hedged is 2.17 . </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax |
During the year ended December 31, 2023, the Company recorded $ 34.8 million in unrealized losses to adjust its cash flow hedges to fair value, which was recorded net of tax to AOCI, and reclassified $ 60.9 million from AOCI as a decrease to interest income on loans. Based on current market conditions, the Company estimates that during the next 12 months, an additional $ 53.1 million related to active and terminated hedges will be reclassified from AOCI as a decrease to interest income. As of December 31, 2023, the maximum length of time over which forecasted transactions are hedged is 2.17 . | text | 60.9 | monetaryItemType | text: <entity> 60.9 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company recorded $ 34.8 million in unrealized losses to adjust its cash flow hedges to fair value, which was recorded net of tax to AOCI, and reclassified $ 60.9 million from AOCI as a decrease to interest income on loans. Based on current market conditions, the Company estimates that during the next 12 months, an additional $ 53.1 million related to active and terminated hedges will be reclassified from AOCI as a decrease to interest income. As of December 31, 2023, the maximum length of time over which forecasted transactions are hedged is 2.17 . </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax |
During the year ended December 31, 2023, the Company recorded $ 34.8 million in unrealized losses to adjust its cash flow hedges to fair value, which was recorded net of tax to AOCI, and reclassified $ 60.9 million from AOCI as a decrease to interest income on loans. Based on current market conditions, the Company estimates that during the next 12 months, an additional $ 53.1 million related to active and terminated hedges will be reclassified from AOCI as a decrease to interest income. As of December 31, 2023, the maximum length of time over which forecasted transactions are hedged is 2.17 . | text | 53.1 | monetaryItemType | text: <entity> 53.1 </entity> <entity type> monetaryItemType </entity type> <context> During the year ended December 31, 2023, the Company recorded $ 34.8 million in unrealized losses to adjust its cash flow hedges to fair value, which was recorded net of tax to AOCI, and reclassified $ 60.9 million from AOCI as a decrease to interest income on loans. Based on current market conditions, the Company estimates that during the next 12 months, an additional $ 53.1 million related to active and terminated hedges will be reclassified from AOCI as a decrease to interest income. As of December 31, 2023, the maximum length of time over which forecasted transactions are hedged is 2.17 . </context> | us-gaap:CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths |
As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. | text | 294 | integerItemType | text: <entity> 294 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. </context> | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. | text | 14 | percentItemType | text: <entity> 14 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. | text | 20 | integerItemType | text: <entity> 20 </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. </context> | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. | text | 20 | percentItemType | text: <entity> 20 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. | text | one | integerItemType | text: <entity> one </entity> <entity type> integerItemType </entity type> <context> As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. </context> | us-gaap:NumberOfRealEstateProperties |
As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. | text | 31 | percentItemType | text: <entity> 31 </entity> <entity type> percentItemType </entity type> <context> As of December 31, 2024, we wholly-owned 294 real estate properties. Additionally, we owned a 14 % interest in Grocery Retail Partners I LLC (“GRP I”), which owned 20 properties, a 20 % interest in Necessity Retail Venture LLC (“NRV”), which owned one property, and a 31 % interest in Neighborhood Grocery Catalyst Fund LLC (“NGCF”), which owned one property. </context> | us-gaap:EquityMethodInvestmentOwnershipPercentage |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.